Non-PHARMAC medicines coverage – aiming for a data-informed evaluation
Non-PHARMAC coverage has become increasingly important to clients purchasing private health insurance, primarily due to rising public demand for treatments and medications not funded by PHARMAC (the government agency overseeing public pharmaceutical purchasing and subsidy).
Non-PHARMAC coverage has become increasingly important to clients purchasing private health insurance, primarily due to rising public demand for treatments and medications not funded by PHARMAC (the government agency overseeing public pharmaceutical purchasing and subsidy).
Recent coverage focused on the severity of a serious illness and whether it can be cured as a potential limitation...MORE»
Sponsored Content
Southern Cross Health Society Group annual results reflect steep increase in demand for private healthcare
Today Southern Cross Health Society Group (“Group”) shares its annual results for the year ended 30 June 2024, highlighting extraordinary growth in claims over the year; in volume and value. MORE »
[Opinion] Life advisers need a mindset change: away from ‘we sell’ to ‘we advise’.Tuesday, April 22nd, 9:52AM
Opinion: Selling is essential in life insurance, but as necessary as it is, it must now be accompanied by suitable advice. We live in a new advice environment – changes are likely needed from what we did before because there are several new expectations. MORE» |
Explaining Non-Pharmac medicines coverageWednesday, April 16th, 8:18AM
|
nib ceo steps down
Rob Hennin has decided to step down as chief executive of nib New Zealand and nib Travel.
MORE»Chubb Life launches moderate trauma cover
New trauma option provides customers with more flexible protection.
MORE»After short delay nib life takes off
nib says its new Ultimate Life and Living Insurance suite of products will be available to advisers from Wednesday after, after delaying the initial launch date.
MORE»Medical premiums and the public system
Most of you will have seen the notices advising increased premiums in the last month, ranging from 16% to 22%.
MORE»